Pueraria Mirifica Benefits: What the Evidence Supports

Pueraria mirifica is a Thai plant root traditionally used for rejuvenation, and today mostly for menopause-related concerns. Small human studies have reported changes in menopausal symptom scores, vaginal health and a bone turnover marker. Evidence for skin is thin, hair is lab-only, and breast growth has no human trial.

What Pueraria Mirifica Is Used For

Pueraria mirifica, called white Kwao Krua in Thailand, is a tuberous root. In Thai tradition the powdered root has been used in rejuvenating preparations for both women and men, according to a review of its medical applications. Today most products, and most research, focus on women around menopause. If you are new to the plant, start with What Is Pueraria Mirifica?.

Its effects are attributed to phytoestrogens, plant compounds that can act on estrogen receptors. They include miroestrol and deoxymiroestrol, which are largely unique to this plant, per a 2022 review in the Thai Journal of Pharmaceutical Sciences.

This article sorts each use by how strong the evidence is: human studies, animal studies, lab cells, or traditional use only. For the overall research picture, see Does Pueraria Mirifica Work?.

Evidence at a Glance

“Small human trial” in this table means dozens of people for a few months. Every row is labeled by who or what was studied, because a result in a rat or a cell dish is not a result in a person.

For the full library of studies, see our Pueraria Mirifica research library.

Menopause Symptoms

This is the best-studied use, though “best-studied” still means small. A trial in 52 women who had had a hysterectomy compared two daily amounts over 6 months and reported lower menopausal symptom scores. An open-label trial in 37 perimenopausal women, with no placebo group, also reported lower scores over 6 months, and listed breast pain, vaginal discharge or bleeding and headache among the effects reported.

Context matters. Phytoestrogens as a group have a mixed record: Cochrane’s review of 43 trials with 4,084 women found no clear overall benefit for hot flushes from phytoestrogen products compared with placebo, although genistein-rich extracts looked worth studying further. A 2026 review of Pueraria mirifica research points to small samples, short follow-up and extracts that differ between studies, and Drugs.com describes the menopause data as limited and of poor quality.

Pueraria mirifica is not a replacement for medical hormone therapy, and nothing here says otherwise. If hot flushes or sleep problems are disrupting your life, a doctor can go through your options with you.

Skin, Hair and Vaginal Comfort

Vaginal comfort

A randomized, double-blind, placebo-controlled trial in 71 postmenopausal women reported lower vaginal dryness symptoms and better markers of vaginal tissue health after 24 weeks of oral capsules. A trial of a topical gel in 72 postmenopausal women reported better vaginal blood flow and vaginal health index scores than a placebo gel. In an animal study, a topical cream improved vaginal tissue measures in postmenopausal macaques. The macaque result tells us about vaginal tissue in that species, not about breast or facial skin.

Skin

A study of a Pueraria mirifica anti-wrinkle cream with 9 participants reported smaller wrinkle surface and volume after 7 and 14 days, with moisturizing similar to comparison creams. That is a very small test. A company press release describes a 28-day serum test with 42 volunteers, sponsored by the extract’s maker. A press release is not a peer-reviewed paper, so treat it as a claim to check, not as proof.

Hair

Hair research is in lab cells only. A cell study found that Pueraria mirifica extract increased the growth of human hair follicle dermal papilla cells in a dose-dependent way, while an older pilot on cultured human hair follicles found no effect from the extract. We found no human trial of Pueraria mirifica for hair.

Breast Care: What Is Known and What Is Not

This is the use readers ask about most, and the one where the gap between marketing and evidence is widest. Here is what is known. Older research in mice and rats, described in a university thesis review, reported mammary duct growth. In people, a 24-week trial in 71 postmenopausal women found no significant difference between the herb and placebo in adverse effects on breast tissue. That is a safety finding, not a growth finding.

Here is what is not known. No published human trial we found measured breast size or shape. A clinical overview on Drugs.com says plainly that there is no literature to support breast enlargement use, even though it is a common marketing claim. So, any promise of a specific result is beyond what the research shows.

If you decide to use a breast product, read its label and ask your doctor first. St.Herb sells Breast Capsules, and the label on the pack is the place to check directions.

Uses With Little or No Evidence

• Weight or body fat. No human data found. In a rat study, body weights fell at higher doses, which is an animal result only.
• Blood lipids. In the 71-woman trial, triglycerides rose by 15 percent in both the herb and placebo groups, so no lipid benefit was shown.
• Cancer. Animal results are mixed. In cancer-primed rats, the herb promoted mammary tumors. There is no human data showing either harm or protection.
• Men’s health, libido and use by transfeminine people. We found no published human trial of oral Pueraria mirifica for these uses. Ask a doctor, especially about hormone therapy.
• Long-term use. A 2026 review flags a lack of long-term safety data.

Who Should Avoid It

Pueraria mirifica acts like an estrogen in some tissues, so it is not for everyone. According to Drugs.com, it should be avoided or used only with medical supervision if you are pregnant or breastfeeding, have a hormone-sensitive cancer, a history of blood clots or liver disease, or take hormonal birth control or other hormone medicines.

Reported effects in trials include breast tenderness, headache and spotting. For the full rundown of side effects and when to stop, read our Pueraria Mirifica side effects and safety guide. And if you are considering it for any reason beyond menopause, talk to a doctor first.

Frequently Asked Questions

What is Pueraria mirifica used for?

Traditionally, it has been used in Thai rejuvenating preparations, per this review of medical applications. Today it is mostly used by women around menopause, for symptoms, vaginal comfort and general wellness. The strength of evidence differs for each use, as the table above shows.

What are the benefits of Pueraria mirifica for women?

The best-supported findings are lower menopausal symptom scores in small trials, such as this trial in 52 women, and better vaginal comfort measures in a trial in 71 women. These are small, short studies, so “benefit” here means “was associated with,” not “guaranteed.”

Does Pueraria mirifica help with menopause?

It was associated with lower symptom scores in small trials, but the wider field of phytoestrogens has a mixed record. Cochrane’s review of 43 trials with 4,084 women found no clear overall benefit for hot flushes from phytoestrogen products compared with placebo. It is not a replacement for medical hormone therapy, and you should ask your doctor about your options.

Is there proof that Pueraria mirifica increases breast size?

No. We found no published human trial that measured it. A clinical overview on Drugs.com says there is no literature to support breast enlargement use, even though it is a common marketing claim. Any promise of a specific result goes beyond the research.

Does Pueraria mirifica help hair or skin?

The evidence is thin. For skin, a study with 9 participants tested a cream. For hair, the research is in cells in a dish only, with a cell study and a pilot that found no effect. Neither has been tested in a proper human trial for hair.

Who should not take Pueraria mirifica?

Pregnant or breastfeeding women, anyone with a hormone-sensitive condition, and people on hormone medicines should avoid it unless a doctor says otherwise, according to Drugs.com. Our safety guide has the full list.